A 63-year-old woman was admitted with an exacerbation of longstanding upper-abdominal pain associated with nausea, vomiting, and rigors. Upper GI endoscopy revealed a small hiatus hernia, and abdominal ultrasound (US) was performed to assess for clinically suspected gallstones. This revealed a well-defined hyperechoic lesion in the liver (Fig.  1 ), considered to be unrelated to presenting symptoms.
AML is a hamartomatous lesion of mesenchymal origin. The precursor cell is believed to be the PEC (perivascular epitheloid cell), and as such has been labeled a PEComa (5) . Histologically, AML is characterized by a mixture of mature fat cells, blood vessels, and smooth muscle cells in various proportions. Hematopoietic cells may also be present. HMB-45 staining is diagnostic of hepatic AML, as seen in this case, as no other primary hepatic tumors stain positive for this (5) .
Radiologically, AML can be diagnosed by demonstrating both fatty and vascular components within the lesion. However, differentiating AML from other fatty lesions of the liver remains difficult (5). On ultrasound, AML appears as a well-defined, hyperechoic lesion with good throughtransmission, although larger lesions tend to have a more mixed echogenicity pattern (6, 7) . AML cannot be differentiated from hemangioma or hyperechoic metastasis on US; both of them are more common than AML. Hemangioma, like AML, is usually an incidental finding that does not give rise to symptoms. More specific features are usually obtained by CT. AML is distinguished by the presence of lowattenuation (less than -20 HU) areas corresponding to fat. However, there have been many reports of AML with minimal fat content not detectable by CT. On contrastenhanced CT, AML tends to show enhancement by 20 to 30 HU. Strong enhancement in the arterial phase reflects the presence of large intralesional vessels, a common finding in larger AML. Rapid contrast washout is commonly seen on the portal venous phase (5). The key point in the diagnosis of AML is to confirm the presence of intralesional fat, which is best demonstrated with in-and out-ofphase T1-weighted gradient imaging (7) . Complications such as tumor hemorrhage can also be seen on MRI (7) .
According to the relevant literature, hepatic AML can be diagnosed pre-operatively based on the following findings: i) Hypervascular nature on imaging, suggesting vascular proliferation within the tumor. ii) Intralesional fat on CT, MRI, and US. iii) Positive actin and HMB-45 stains on biopsy specimen, which proves smooth muscle component (8). In our case, surgery could have potentially been avoided if the correct diagnosis had been made preoperatively. Although the combination of US, CT, MRI, and occasionally angiography increases the accuracy in diagnosis of hepatic AML, the correct preoperative diagnostic rate of imaging studies has been reported to be less than 50% (3, 9, 10) .
Preoperative identification of AML is desirable because of differences in clinical course and treatment between this disease and other hepatic neoplasms. The key imaging finding of AML in all organs is intralesional fat, although the differential diagnosis of a fat-containing liver lesion is wide. In these cases, the possibility of hepatic AML, although rare, should be considered. 
